nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Autophagy is a therapeutic target in anticancer drug resistance
|
Chen, Suning |
|
2010 |
1806 |
2 |
p. 220-229 10 p. |
artikel |
2 |
Cellular and soluble markers of tumor angiogenesis: From patient selection to the identification of the most appropriate postresistance therapy
|
Bertolini, Francesco |
|
2010 |
1806 |
2 |
p. 131-137 7 p. |
artikel |
3 |
Cisplatin resistance: Preclinical findings and clinical implications
|
Köberle, Beate |
|
2010 |
1806 |
2 |
p. 172-182 11 p. |
artikel |
4 |
Crosstalk and DC-SCRIPT: Expanding nuclear receptor modulation
|
Ansems, M. |
|
2010 |
1806 |
2 |
p. 193-199 7 p. |
artikel |
5 |
Dissecting the transcriptional functions of human DNA topoisomerase I by selective inhibitors: Implications for physiological and therapeutic modulation of enzyme activity
|
Capranico, Giovanni |
|
2010 |
1806 |
2 |
p. 240-250 11 p. |
artikel |
6 |
Editorial Board
|
|
|
2010 |
1806 |
2 |
p. i- 1 p. |
artikel |
7 |
Implications of cancer-associated systemic inflammation for biomarker studies
|
Kowalewska, Magdalena |
|
2010 |
1806 |
2 |
p. 163-171 9 p. |
artikel |
8 |
Protein kinase D as a potential new target for cancer therapy
|
LaValle, Courtney R. |
|
2010 |
1806 |
2 |
p. 183-192 10 p. |
artikel |
9 |
Reversible phosphorylation in haematological malignancies: Potential role for protein tyrosine phosphatases in treatment?
|
Ruela-de-Sousa, Roberta R. |
|
2010 |
1806 |
2 |
p. 287-303 17 p. |
artikel |
10 |
Role of cadherin-17 in oncogenesis and potential therapeutic implications in hepatocellular carcinoma
|
Lee, Nikki P. |
|
2010 |
1806 |
2 |
p. 138-145 8 p. |
artikel |
11 |
Serum microRNAs as powerful cancer biomarkers
|
Wittmann, Jürgen |
|
2010 |
1806 |
2 |
p. 200-207 8 p. |
artikel |
12 |
Targeting Notch signaling pathway to overcome drug resistance for cancer therapy
|
Wang, Zhiwei |
|
2010 |
1806 |
2 |
p. 258-267 10 p. |
artikel |
13 |
TBX2 and TBX3: The special value for anticancer drug targets
|
Lu, Juan |
|
2010 |
1806 |
2 |
p. 268-274 7 p. |
artikel |
14 |
The Aurora-A/TPX2 complex: A novel oncogenic holoenzyme?
|
Asteriti, Italia Anna |
|
2010 |
1806 |
2 |
p. 230-239 10 p. |
artikel |
15 |
The HGF/MET pathway as target for the treatment of multiple myeloma and B-cell lymphomas
|
Mahtouk, Karène |
|
2010 |
1806 |
2 |
p. 208-219 12 p. |
artikel |
16 |
The stem cell code in oral epithelial tumorigenesis: ‘The cancer stem cell shift hypothesis’
|
Richard, Vinitha |
|
2010 |
1806 |
2 |
p. 146-162 17 p. |
artikel |
17 |
The translational regulator eIF3a: The tricky eIF3 subunit!
|
Saletta, Federica |
|
2010 |
1806 |
2 |
p. 275-286 12 p. |
artikel |
18 |
Validating cancer drug targets through chemical genetics
|
Burkard, Mark E. |
|
2010 |
1806 |
2 |
p. 251-257 7 p. |
artikel |